UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Inotuzumab Ozogamicin in Adult Patients with Relapsed or Reractory ALL
    Thomas Carter
  2. A Phase II Study of Neoadjuvant Letrozole for Post-Menopausal Women with Estrogen Receptor Positive Ductal Carcinoma In Situ
    Alexandra Thomas
  3. A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed At Time of Radial Cystectomy For Muscle Invasive Urothelial Cancer
    Daniel Vaena
  4. Well Woman Tissue Repository
    Donna Santillan
  5. Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
    Joseph Cullen MD
  6. An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
    Daniel Vaena
  7. The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE Study)
    William Sivitz
  8. A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Ca…
    Daniel Vaena
  9. A Randomized, Phase III Study of Standard Dosing versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer (VAMC)
    Daniel Vaena
  10. ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease Prostate Cancer (VAMC)
    Daniel Vaena
  11. Killer Immunoglobulin-like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Stem Cell Transplantation (SCT) for AML with Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory and Relapsed Acute…
    Ayman El-Sheikh
  12. A Randomized Phase 2 Trial of 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) with Ketoconazole in Patients with High Risk Castrate Biochemically Relapsed Prostate Cancer After Local Therap…
    Daniel Vaena
  13. LY2875358 + Erlotinib and LY2875358 Monotherapy, MET Positive NSCLC w/ Resistance to Erlotinib
    Taher Abu Hejleh
  14. A Randomized Phase II Study of NCI Supplied Cabozantinib (NSC #761968 IND #116059) versus weekly paclitaxel (NSC #673089) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube…
    David Bender
  15. A Phase 3 Study to Evaluate the Efficacy and Safety of Dinaciclib or Ofatumumab in Subjects with Refractory Chronic Lymphocytic Leukemia
    Thomas Carter
  16. A Phase I Study of Intravenous Carboplatin/Paclitaxel or Intravenous and Intraperitoneal Paclitaxel/Cisplatin in Combination with Continuous or Intermittent CTEP-Supplied Agent ABT-888 (NSC #737664, I…
    David Bender
  17. A Pilot Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcoma (40)
    Mohammed Milhem
  18. An Open-Label, Multicenter, Randomized, Phase III Study to Investigate the Efficacy and Safety of Bendamustine Compared with Bendamustine + RO5072759 (GA101) in Patients with Rituximab-Refractory, Ind…
    Brian Link
  19. Cytogenetic Studies in Acute Leukemia
    Daniel Vaena
  20. A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemo-Naïve Sex Cord-Stromal Tumors of the Ovary
    David Bender

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.